An interventional study of JASPER™ Robotic Surgical System in Cataract, sponsored by ForSight Robotics Ltd. Recruiting at 1 site in Philippines. Open to participants aged 55 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-07-24.
Sponsored by ForSight Robotics Ltd · Not applicable, Interventional, and Treatment
This is a prospective, open-label clinical study designed to evaluate the performance and safety of the JASPER™ Robotic Surgical System during cataract surgery.
Main Inclusion Criteria:
Main Exclusion Criteria:
Subjects will undergo cataract surgery using the JASPER™ Robotic Surgical System.
Device: JASPER™ Robotic Surgical System
The JASPER™ Robotic Surgical System is a robotically assisted surgical system intended to assist ophthalmic surgeons in performing cataract surgery.
Successful completion of planned Robotic-Assisted cataract surgery
Proportion of study eyes in which the planned robotic cataract surgery is completed using the JASPER™ Robotic Surgical System without conversion to manual technique.
Time frame: Intra-operative
Incidence and Type of Adverse Events (AEs) and Serious Adverse Events (SAEs)
Incidence and type of all AEs and SAEs occurring intraoperatively and during the postoperative follow-up period.
Time frame: From surgery through 30 days post-procedure
Distribution of pre and postoperative Best Corrected Visual acuity
Distribution of preoperative and postoperative BCVA
Time frame: Baseline and up to 30 days post-procedure
Postoperative Ophthalmic examination findings
Postoperative slit lamp and dilated fundus examinations findings
Time frame: Up to 30 days post-procedure
Plan to share: No — Individual participant data (IPD) will not be shared at this time due to privacy, confidentiality, and regulatory considerations. Future sharing may be considered under appropriate agreements and conditions.
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.